These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
354 related articles for article (PubMed ID: 2826994)
1. 2',3'-Dideoxycytidine: regulation of its metabolism and anti-retroviral potency by natural pyrimidine nucleosides and by inhibitors of pyrimidine nucleotide synthesis. Balzarini J; Cooney DA; Dalal M; Kang GJ; Cupp JE; DeClercq E; Broder S; Johns DG Mol Pharmacol; 1987 Dec; 32(6):798-806. PubMed ID: 2826994 [TBL] [Abstract][Full Text] [Related]
2. 2',3'-Dideoxycytidine toxicity in cultured human CEM T lymphoblasts: effects of combination with 3'-azido-3'-deoxythymidine and thymidine. Törnevik Y; Eriksson S Mol Pharmacol; 1990 Aug; 38(2):237-43. PubMed ID: 2166904 [TBL] [Abstract][Full Text] [Related]
3. Differential affinities of pyrimidine nucleoside analogues for deoxythymidine and deoxycytidine kinase determine their incorporation into murine leukemia L1210 cells. Balzarini J; De Clercq E Acta Biochim Pol; 1987; 34(2):63-77. PubMed ID: 2823514 [TBL] [Abstract][Full Text] [Related]
4. The in vitro and in vivo anti-retrovirus activity, and intracellular metabolism of 3'-azido-2',3'-dideoxythymidine and 2',3'-dideoxycytidine are highly dependent on the cell species. Balzarini J; Pauwels R; Baba M; Herdewijn P; de Clercq E; Broder S; Johns DG Biochem Pharmacol; 1988 Mar; 37(5):897-903. PubMed ID: 2830886 [TBL] [Abstract][Full Text] [Related]
5. Cellular metabolism of 2',3'-dideoxycytidine, a compound active against human immunodeficiency virus in vitro. Starnes MC; Cheng YC J Biol Chem; 1987 Jan; 262(3):988-91. PubMed ID: 2433280 [TBL] [Abstract][Full Text] [Related]
6. Anti-retrovirus activity of 3'-fluoro- and 3'-azido-substituted pyrimidine 2',3'-dideoxynucleoside analogues. Balzarini J; Baba M; Pauwels R; Herdewijn P; De Clerq E Biochem Pharmacol; 1988 Jul; 37(14):2847-56. PubMed ID: 2840080 [TBL] [Abstract][Full Text] [Related]
7. The anti-HTLV-III (anti-HIV) and cytotoxic activity of 2',3'-didehydro-2',3'-dideoxyribonucleosides: a comparison with their parental 2',3'-dideoxyribonucleosides. Balzarini J; Kang GJ; Dalal M; Herdewijn P; De Clercq E; Broder S; Johns DG Mol Pharmacol; 1987 Jul; 32(1):162-7. PubMed ID: 3648476 [TBL] [Abstract][Full Text] [Related]
8. Role of deoxycytidine kinase in the inhibitory activity of 5-substituted 2'-deoxycytidines and cytosine arabinosides on tumor cell growth. Balzarini J; De Clercq E Mol Pharmacol; 1983 Jan; 23(1):175-81. PubMed ID: 6306422 [TBL] [Abstract][Full Text] [Related]
9. Characterization of 2',3'-dideoxycytidine diphosphocholine and 2',3'-dideoxycytidine diphosphoethanolamine. Prominent phosphodiester metabolites of the anti-HIV nucleoside 2',3'-dideoxycytidine. Hao Z; Stowe EE; Ahluwalia G; Baker DC; Hebbler AK; Chisena C; Musser SM; Kelley JA; Perno CF; Johns DG Drug Metab Dispos; 1993; 21(4):738-44. PubMed ID: 7690699 [TBL] [Abstract][Full Text] [Related]
11. Effects of deoxynucleosides on cultured human leukemia cell growth and deoxynucleotide pools. Ross DD; Akman SA; Schrecker AW; Bachur NR Cancer Res; 1981 Nov; 41(11 Pt 1):4493-8. PubMed ID: 6975653 [TBL] [Abstract][Full Text] [Related]
12. Pyrimidine deoxynucleoside and nucleoside reverse transcriptase inhibitor metabolism in the perfused heart and isolated mitochondria. Morris GW; Laclair DD; McKee EE Antivir Ther; 2010; 15(4):587-97. PubMed ID: 20587852 [TBL] [Abstract][Full Text] [Related]
13. Incorporation of 5-substituted pyrimidine nucleoside analogues into DNA of a thymidylate synthetase-deficient murine FM3A carcinoma cell line. Balzarini J; De Clercq E; Ayusawa D; Seno T Methods Find Exp Clin Pharmacol; 1985 Jan; 7(1):19-28. PubMed ID: 3990443 [TBL] [Abstract][Full Text] [Related]
14. Comparison of in vitro and in vivo effects of thymidine on L1210 leukemia in mice. Zaharko DS; Ramonas LM J Natl Cancer Inst; 1982 May; 68(5):875-80. PubMed ID: 6951095 [TBL] [Abstract][Full Text] [Related]
15. Modulation of deoxycytidine metabolism in vivo with high-dose thymidine in mice. Zaharko DS; Covey JM J Natl Cancer Inst; 1983 Nov; 71(5):1033-9. PubMed ID: 6580479 [TBL] [Abstract][Full Text] [Related]
16. Factors determining the activity of 2',3'-dideoxynucleosides in suppressing human immunodeficiency virus in vitro. Hao Z; Cooney DA; Hartman NR; Perno CF; Fridland A; DeVico AL; Sarngadharan MG; Broder S; Johns DG Mol Pharmacol; 1988 Oct; 34(4):431-5. PubMed ID: 2459590 [TBL] [Abstract][Full Text] [Related]
17. Dose- and schedule-dependent activation and drug synergism between thymidine and 5-aza-2'-deoxycytidine in a human promyelocytic leukemia cell line. Grant S; Rauscher F; Margolin J; Cadman E Cancer Res; 1982 Feb; 42(2):519-24. PubMed ID: 6173114 [TBL] [Abstract][Full Text] [Related]
18. In vitro toxicity and metabolism of 2',3'-dideoxycytidine, an inhibitor of human immunodeficiency virus infectivity. Brandi G; Rossi L; Schiavano GF; Salvaggio L; Albano A; Magnani M Chem Biol Interact; 1991; 79(1):53-64. PubMed ID: 1647888 [TBL] [Abstract][Full Text] [Related]
19. [Anti-retroviral activity and molecular-biochemical action mechanism of 2',3'-dideoxynucleoside analogs and 9-(2-phosphonylmethoxyethyl) purine derivatives]. Balzarini J Verh K Acad Geneeskd Belg; 1991; 53(1):61-98. PubMed ID: 1647085 [TBL] [Abstract][Full Text] [Related]
20. Selective activation of deoxycytidine kinase by thymidine-5'-thiosulphate and release by deoxycytidine in human lymphocytes. Keszler G; Szikla K; Kazimierczuk Z; Spasokoukotskaja T; Sasvari-Szekely M; Staub M Biochem Pharmacol; 2003 Feb; 65(4):563-71. PubMed ID: 12566083 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]